Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Blood Advances|November 21, 2018
Onsets of progression and second treatment determine survival of patients with symptomatic Waldenström macroglobulinemiaStephanie Guidez, Julien Labreuche, Elodie Drumez, et al.
Cancer Epidemiology|April 6, 2025
Are oldest old patients with diffuse large B-cell lymphoma different than their younger counterparts: Results from the REALYSA real-life cohortChristelle Cantrelle, Aurélien Belot, Alain Monnereau, et al.
Plos One|October 18, 2016
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C StudyLaurent Alric, Caroline Besson, Nathanael Lapidus, et al.
Hematological Oncology|April 6, 2022
Does early disease progression predict survival after first line-treatment of Waldenström macroglobulinemia?Julien Labreuche, Deborah Assouan, Eric Durot, et al.
The Journal of Pathology|June 3, 2024
Integrated spatial and multimodal single-cell transcriptomics reveal patient-dependent cell heterogeneity in splenic marginal zone lymphomaJuan Pablo Cerapio, Pauline Gravelle, Anne Quillet-Mary, et al.
Current Drug Targets|April 8, 2010
Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodiesAude-Hélène Capietto, Samarh Keirallah, Emilie Gross, et al.
Blood|March 13, 2012
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantationWendy Cuccuini, Josette Briere, Nicolas Mounier, et al.
Annals of Hematology|July 30, 2025
Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Blood|December 3, 2010
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 studyArnaud Jaccard, Nathalie Gachard, Benoit Marin, et al.
British Journal of Haematology|September 10, 2016
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective studyPhilip A Thompson, Vincent Lévy, Constantine S Tam, et al.
Pageof 7